The known clinical hair phenotype associated with Laron syndrome or reduced GH serum levels (Table 2), which is also associated with decreased expression of IGF-1, would have led one to expect that the growth of organ-cultured human scalp HFs would be promoted by GH treatment. Here, IGF1 is linked to Laron syndrome.